NASDAQ · CCLDO
Healthcare · Medical - Healthcare Information Services
$27.44
Up+$0.00 (+0.00%)
Updated Sep 14, 2026, 7:54 PM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
CCLDO does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning CCLDO.
CCLDO research
Company profile and research snapshot.
CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Mar 14, 2025 | Roth MKM | Neutral | — |
| Nov 15, 2024 | Benchmark | Buy | — |
| Aug 27, 2024 | Benchmark | Buy | — |
| May 16, 2024 | Benchmark | Buy | — |
| Mar 25, 2024 | Benchmark | Buy | — |
No generated briefing is available yet.
Yahoo · Dec 9, 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Yahoo · Dec 1, 2025
CareCloud stock has garnered renewed attention as the consensus analyst price target has edged upward, rising from $5.75 to $6.31 per share. This change reflects a mix of optimism about the company’s execution as well as ongoing caution over its growth trajectory. Stay tuned to discover how investors can keep informed on evolving analyst perspectives and the shifting narrative around CareCloud’s market performance. Analyst Price Targets don't always capture the full story. Head over to our...
Yahoo · Nov 17, 2025
CareCloud’s stock has seen a recent increase in its fair value price target from $4.75 to $5.75, reflecting a more optimistic outlook from analysts. This adjustment comes as a result of improved cost controls and a stronger near-term earnings outlook. However, analysts remain cautious given persistent uncertainties. Stay tuned to find out how you can follow future shifts in CareCloud’s evolving story. Analyst Price Targets don't always capture the full story. Head over to our Company Report...
globenewswire.com · Nov 10, 2025
Plan Based on Growing Recurring Revenues and Margins; Double Dividends Expected to Continue until Series B Dividend Arrears are Fully Satisfied SOMERSET, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”) today announced that its Board of Directors has adopted a formal plan (the “Plan”) to satisfy the 14 months of accumulated and unpaid dividends (i.e.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CCLDO.
No results
No recent SID articles mention CCLDO.
